Search results
Found 17940 matches for
All Oxford students are invited to take part in the U-Flourish survey from 22 October 2020. The aim of the project is to better understand the factors that contribute to student wellbeing, mental health, and academic success, particularly how the COVID-19 pandemic has affected students and their learning.
The Oxford FAD Study - Food for ADHD and Depression
Researchers at The University of Oxford are investigating diet for ADHD and depression.
Race and Psychiatry Journal Club
Our mission is to advance racial health equity and investigate how racism and discrimination affect mental health outcomes.
BE-GUIDED Study: Evaluating a digital guided self-help programme for binge eating
CREDO (https://www.psych.ox.ac.uk/research/credo) are testing the feasibility of a trial to evaluate a digital guided self-help programme for binge eating. Binge Eating Disorder is a common mental health problem which can impact people’s psychological and physical health and their quality of life, affecting around 3% of the population. Guided self-help (GSH) is recommended as the first step in the treatment of Binge Eating Disorder. The Centre for Research on Eating Disorders at Oxford (CREDO) had developed a new digital programme. Digitalising treatment for Binge Eating Disorder is likely to improve its effectiveness and cost-effectiveness, and it may also make it easier to access. If true, this will reduce the suffering of people with binge eating disorder.
PUMA team and Collaborators
PUMA is truly a team effort. Here you can learn more about our team, working groups and collaborators.
PUMA Working Groups
This page provides and overview of the PUMA trial's working groups set up to develop a Multi-arm multi-stage (MAMS) platform for Early Psychosis. You will find the aims rationale and plan for each group below.
Get involved with PUMA
PUMA is not currently recruiting but check back soon for updates!
Early Psychosis Multi-arm, Multi-stage Platform Trial (PUMA)
With lived-experience involvement being central to their design and implementation, multi-arm multi-stage (MAMS) trials have revolutionised clinical trials methodology, updated standard-of-care and resulted in improved patient outcomes in many illnesses. As mechanistically-based experiments they also illuminate underlying biology. The PUMA project aims a similar transformation for the treatment of early psychosis.